Farmaceutica REMEDIA S.A. Share Price

Equities

RMAH

RORMAHACNOR2

Drug Retailers

End-of-day quote Bucharest S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
0.704 RON +0.28% Intraday chart for Farmaceutica REMEDIA S.A. +2.03% +4.30%

Financials

Sales 2021 477M 103M 8.57B Sales 2022 536M 115M 9.62B Capitalization 56.16M 12.1M 1.01B
Net income 2021 7M 1.51M 126M Net income 2022 5M 1.08M 89.78M EV / Sales 2021 0.09 x
Net cash position 2021 22.88M 4.93M 411M Net cash position 2022 16.88M 3.64M 303M EV / Sales 2022 0.07 x
P/E ratio 2021
9.21 x
P/E ratio 2022
9.7 x
Employees 223
Yield 2021
7.16%
Yield 2022
8.47%
Free-Float 18.24%
More Fundamentals * Assessed data
Dynamic Chart
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Farmaceutica REMEDIA S.A. Announces Earnings Results for the Half Year Ended June 30, 2021 CI
Farmaceutica REMEDIA S.A. Reports Earnings Results for the First quarter Ended March 31, 2021 CI
Farmaceutica Remedia S.A. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Farmaceutica Remedia S.A. Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
More news
1 day+0.28%
1 week+2.03%
Current month-0.85%
1 month-0.14%
3 months+4.30%
6 months+6.67%
Current year+4.30%
More quotes
1 week
0.69
Extreme 0.692
0.70
1 month
0.69
Extreme 0.688
0.72
Current year
0.65
Extreme 0.65
0.72
1 year
0.60
Extreme 0.6
0.72
3 years
0.51
Extreme 0.51
1.00
5 years
0.34
Extreme 0.342
1.02
10 years
0.17
Extreme 0.171
1.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 72 12/07/12
Director of Finance/CFO 41 01/06/01
Chief Tech/Sci/R&D Officer 49 01/01/01
Members of the board TitleAgeSince
Chief Executive Officer 72 12/07/12
Corporate Officer/Principal 69 12/07/12
Director/Board Member 50 01/05/01
More insiders
Date Price Change Volume
26/24/26 0.704 +0.28% 8,070
25/24/25 0.702 +0.57% 19,694
24/24/24 0.698 -0.57% 2,649
23/24/23 0.702 +1.74% 750
22/24/22 0.69 0.00% 5,125

End-of-day quote Bucharest S.E., April 26, 2024

More quotes
Farmaceutica Remedia SA is a Romania-based company principally engaged in the operation of pharmacies. The Company is active in the marketing, import and distribution of drugs. Additionally, it sells packing materials for pharmaceutical industry. The company operates approximately a network of 100 pharmacies and drugstores placed in Alba, Arad, Bucharest, Calarasi, Cluj, Dambovita, Dolj, Giurgiu, Hunedoara, Ilfov, Sibiu, Timis and Tulcea. Farmaceutica Remedia also operates eight logistic centers in Bucuresti, Deva, Brasov, Craiova, Iasi, Pitesti, Sibiu, Tg. Mures and Timisoara. The Company’s major shareholders are Tarus Valentin-Norbert, which owns 66.06% of shares, and AHG Vermogensverwaltungs GmbH Cottbus with 16.5%.
More about the company